HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. 1992

P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
Institute of Molecular Medicine, Oxford, England.

We have investigated the role of HLA-DR genotypes in 184 patients with severe rheumatoid arthritis (RA) and in 46 patients with Felty syndrome, to establish the relative contribution of the RA-associated subtypes of DR4 (Dw4, Dw14, and Dw15). There was an excess of DR4 homozygotes, particularly Dw4/Dw14 compound heterozygotes (relative risk [RR] 49). The risk associated with Dw4 depended on the other allele present--Dw4/DR1 (RR 21), Dw4/Dw4 (RR 15), and Dw4/DRX (RR 6). There was a significant risk from Dw4/Dw14 compared with Dw4/Dw4, both in those with severe RA (RR 2.9; P less than .02) and in those with Felty syndrome (RR 4.2; P less than .02). In contrast, in a further 63 known DR4 homozygotes with RA, not selected for severe disease, the excess of Dw4/Dw14 was much less striking (RR 1.4; not significant), suggesting that this genotype may be particularly associated with more severe disease. We also found four cases with the rare Dw4/Dw15 genotype (expected less than or equal to 0.5; P less than or equal to .02). Since the Dw4, Dw14, Dw15, and DR1 molecules have similar antigen-binding sites and since combinations of these alleles particularly predispose to severe RA, we suggest that synergistic mechanisms are involved. These could include an effect on T-cell repertoire selection.

UI MeSH Term Description Entries
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015798 HLA-DR1 Antigen An HLA-DR antigen associated with HLA-DRB1 CHAINS that are encoded by DRB1*01 alleles. HLA-DR1,Antigen, HLA-DR1,HLA DR1 Antigen
D015804 HLA-DR4 Antigen An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*04 alleles. HLA-DR4,Antigen, HLA-DR4,HLA DR4 Antigen

Related Publications

P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
August 1991, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
November 1985, Tissue antigens,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
January 1997, Transplantation proceedings,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
April 1988, Tissue antigens,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
April 1991, British journal of rheumatology,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
January 2000, Clinical and experimental rheumatology,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
June 1986, Disease markers,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
January 2007, BMC proceedings,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
June 1992, Bailliere's clinical rheumatology,
P Wordsworth, and K D Pile, and J D Buckely, and J S Lanchbury, and B Ollier, and M Lathrop, and J I Bell
November 1990, The Journal of rheumatology. Supplement,
Copied contents to your clipboard!